By Suzanne Burdick, Ph.D. | The Defender | October 26, 2022 The U.S. Food and Drug Administration (FDA) took more than a year to follow up on a potential increase in serious adverse events in elderly people who received Pfizer’s COVID-19 vaccine, according to an investigative report published Tuesday by The BMJ. According to The BMJ, in July […]
Source